DEA Extends Prescribing Controlled Substances Via Telehealth For 6 Months

May 11, 2023

The U.S. Drug Enforcement Administration (DEA) is extending the ability for physicians to prescribe controlled substances based on telehealth visits through November 11, 2023. This method had been set to expire when the COVID-19 Public Health Emergency ended today (May 11).  

On March 1, the DEA and the Department of Health and Human Services (HHS), sent out notices of proposed rulemakings (NPRMs) to generate feedback on proposals to continue allowing the prescribing of controlled medications via virtual visits with patients. More than 38,000 public comments came in.  

“These medications, including those used to treat opioid use disorder, are a vital form of care for millions of Americans who have come to rely on safe and effective telemedicine appointments,” said the AMA in a statement. “Patients being treated with these medications often have challenges securing and traveling to in-person appointments.” 

Latest News

Negotiations Continue, Special Session Coming Soon?

May 29, 2025

As the Legislature works to complete its work on the state’s two-year budget, another deadline is looming. Legislators are required to pass a balanced budget before the end of the fiscal year—June 30, 2025. If they don’t meet that deadline, the state will begin a partial shutdown. 

Register Today for the Empowering Physicians Event Featuring Elisabeth Rosenthal, MD

May 29, 2025

Registration has opened for the Empowering Physicians: A Night of Reflection and Engagement event, featuring best-selling author Elisabeth Rosenthal, MD.   

AMA Urges Docs to Protect Medicaid by Contacting Congress

May 29, 2025

The AMA is encouraging physicians to contact their U.S. senators and urge them to revise the reconciliation bill passed recently by the U.S. House of Representatives. While the bill includes language that would stabilize Medicare physician payments, it also threatens to cripple Medicaid and CHIP.